Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 5.89% vs 1.19% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 182.14% vs -26.61% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 27.08% vs -2.51% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -25.93% vs -2.70% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Harbin Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 5.89% vs 1.19% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.02% vs 0.78% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 182.14% vs -26.61% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -26.34% vs 14.92% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 27.08% vs -2.51% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -38.14% vs 11.10% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -25.93% vs -2.70% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -23.81% vs -23.36% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






